Abbvie Header week 48

Abbvie Header week 48

X

Find the latest and updated news related to category america aggregated by PharmaCompass.com.

News
america

Latest pharma news

Pharma news by category

All product launches & approvals

All quality compliance alerts

America

India

Europe

Asia

Generics

APIs

Quality

Science

Rare Diseases

Others

Subscribe

Dermata Announces Topline Results DMT310 Ph2 Trial forModerate-to-Severe Rosacea

Dermata Announces Topline Results DMT310 Ph2 Trial forModerate-to-Severe Rosacea

PRESS RELEASE

06 Dec 2022

Pfizer`s expansion continues with $750M investment in Michigan

Pfizer`s expansion continues with $750M investment in Michigan

Fraiser Kansteiner FIERCEPHARMA

06 Dec 2022

Loan default, Rubraca move inches Clovis closer to bankruptcy

Loan default, Rubraca move inches Clovis closer to bankruptcy

Kevin Dunleavy FIERCEPHARMA

06 Dec 2022

Share

Do Verve`s gene edits pass down to patients` children? The FDA wants to know

Do Verve`s gene edits pass down to patients` children? The FDA wants to know

Nick Paul Taylor FIERCEBIOTECH

06 Dec 2022

Share

Nkarta underscores safety of CAR-NK, boasts early responses

Nkarta underscores safety of CAR-NK, boasts early responses

Amber Tong ENDPTS

06 Dec 2022

Qilu Pharma Latest Results of QL1604 plus Chemotherapy as First-Line Treatment

Qilu Pharma Latest Results of QL1604 plus Chemotherapy as First-Line Treatment

BIOSPACE

05 Dec 2022

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne

TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne

BUSINESSWIRE

05 Dec 2022

Share

AG Derek Schmidt files lawsuit alleging illegal practices insulin prices

AG Derek Schmidt files lawsuit alleging illegal practices insulin prices

AGKS

04 Dec 2022

Share

Recro Pharma Will Pay $1.4 Million Under Shareholder Settlement

Recro Pharma Will Pay $1.4 Million Under Shareholder Settlement

BLOOMBERGLAW

04 Dec 2022

Istesso announces FDA Fast Track and Orphan Drug designation for MBS2320

Istesso announces FDA Fast Track and Orphan Drug designation for MBS2320

PRESS RELAESE

04 Dec 2022